KIDNEY C.O.P. Calcium Oxalate Protector – 120 Capsules – Patented Delayed-Release Formula – 3 Pack

Overview

KIDNEY C.O.P. Calcium Oxalate Protector is a thoughtfully engineered dietary supplement designed to support urinary health and kidney comfort as part of a balanced daily routine. Each bottle contains 120 capsules, and this 3-pack option provides extended value for ongoing use.

With a focus on absorption, the delayed-release capsule targets the intestines rather than the stomach, aiming for steadier utilization throughout the day. The product builds on a lineage of patent-backed formulation and science-driven testing, offering a careful balance of traditional ingredients and modern delivery technology.

Key benefits and features

• Patented delayed-release capsule to optimize absorption in the intestines.
• Claims of 99% reduction in the rate of calcium oxalate stone growth are reported in documented tests (details available on request).
• Reported potency: described as five times more powerful than a commonly cited extract in a 2018 study (details available on request).
• Ingredients are noted to support related kidney function, urinary health, and detoxification processes in supporting documentation.
• Five U.S. patents back the innovative formulation, indicating a unique approach within this category.

Real‑world use and daily routine

In everyday life, small capsules can become a simple part of your morning and evening routine. The delayed-release design is intended to place the absorption focus where it can be most effective across the day, potentially aligning with a steady daily habit for urinary health support.

What’s in the pack

• Three bottles bundled together, each with 120 capsules for extended use.
• Clear labeling to help track daily intake and maintain consistency over time.

Notes on usage and transparency

Follow label directions and consult with a healthcare professional if you are pregnant, nursing, or taking medications. This product is not intended to diagnose, treat, cure, or prevent disease. Details on the cited tests and patents are available upon request.